Cheng-Shun
Cheng-Shun Chen, Taipei City TW
Patent application number | Description | Published |
---|---|---|
20110288631 | Preventing Vascular Stenosis of Cardiovascular Stent - A novel cardiovascular stent for preventing vascular stenosis is disclosed. The basic components of the cardiovascular stent of the present invention include V-shape rib unit, multi-link unit and connective ring unit. In addition, each ring rib part is formed by a plurality of double V-shape rib units that are connected together via the bridging portions of the multi-link units. Also, each connective part comprises a plurality of connective ring units. The integrally formed stent of the present invention is formed with the ring rib parts that are connected together by the connective parts. | 11-24-2011 |
Cheng-Shun Jiang, Taoyuan County TW
Patent application number | Description | Published |
---|---|---|
20130143102 | BATTERY ASSEMBLING DEVICE - A battery assembling device has two brackets and an assembling unit. The brackets abut each other and can be securely mounted around two battery units. The assembling unit has a quick-release housing and two clamps. The quick-release housing has two electrode holes. The clamps are respectively mounted in the electrode holes and each clamp has two opposite threaded inner surfaces. The battery units can be bundled by the brackets in advance to form regular battery modules. Because the assembling unit is easily and quickly connected with the battery modules, the assembling of a cell of an electrical vehicle is greatly convenient and fast. | 06-06-2013 |
Cheng-Shun Lai, Sinying City TW
Patent application number | Description | Published |
---|---|---|
20090318488 | Pharmaceutically acceprable salts of aporphine compounds of carboxyl group-containing agents and methods for preparing the same - The present invention discloses novel pharmaceutically acceptable salts of aporphine compounds and carboxyl-group containing agents. Also, the present invention discloses methods for preparing the pharmaceutically acceptable salts. These pharmaceutically acceptable salts are suitable for use in treating and/or preventing hyperglycemic disease and/or several oxidative stress related diseases. | 12-24-2009 |
20090318489 | Aporphine compounds and pharmaceutical use thereof - The present invention discloses novel aporphine derivatives. Also, the present invention discloses that these novel aporphine derivatives can be used for treating oxidative stress induced diseases such as cardiovascular disease, diabetes, aging, Alzheimer's disease, kidney disease, cancer or brain ischemic disease etc. | 12-24-2009 |
Cheng-Shun Lai, Tainan City TW
Patent application number | Description | Published |
---|---|---|
20130012464 | GLYCYRRHIZINATES OF MORPHINAN DERIVATIVES - The present invention provides a pharmaceutically acceptable compound, a pharmaceutical composition comprising the above-mentioned pharmaceutically acceptable compound. The pharmaceutically acceptable compound provided by the present invention is a salt of a basic group-containing morphinan derivative and a carboxyl group-containing glycyrrhizinic acid and has the ability to be used to manufacture medicaments for treating and/or preventing cough, ameliorating pains, treating respiratory system diseases, treating cardiovascular diseases and treating liver diseases. | 01-10-2013 |